Login to Your Account



Pharma: Other news to note


Thursday, January 9, 2014
Bristol-Myers Squibb Co., of Princeton, N.J., and partner Astrazeneca plc, of London, said the FDA approved Farxiga (dapagliflozin) tablets to improve glycemic control, along with diet and exercise in adults with Type II diabetes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription